Emboline Announces First U.S. Commercial Use of the Emboliner® Embolic Protection System

Contributed by: PR Newswire

Tags

Emboline-Inc

More Like This

PR Newswire associated0

Emboline Receives U.S. FDA 510(k) Clearance for Emboliner® Embolic Protection System

Emboline, Inc. Completes Enrollment in U.S. Pivotal IDE Trial of the Emboliner® Embolic Protection Catheter Designed to Protect Patients from Embolic Injury During Transcatheter Aortic Valve Replacement

PR Newswire associated0

Emboline, Inc. Secures $20 Million in Growth Capital from Trinity Capital Inc. to Support Commercialization of the Emboliner® Embolic Protection System to Minimize Stroke Risk From TAVR

Emboline, Inc. Files Patent Infringement Suit Against AorticLab s.r.l. Regarding Embolic Protection Medical Device

PR Newswire associated0

Emboline Announces Positive Pivotal PROTECT H2H Trial Results for Emboliner® Presented as a Late-Breaking Clinical Trial at ACC 2026

PR Newswire associated0

Emboline Prevails in German Utility Model Infringement Action Against AorticLab

Protembis Announces FDA Approval of its Pivotal Investigational Device Exemption (IDE) Study

Protembis Announces First Patient Enrolled in the PROTEMBO IDE Pivotal Trial